Contact
searchSearch
HMP Global

Q&As

Alexis Ogdie, MD
Q&As
Alexis Ogdie, MD, on Achieving Minimal Disease Activity Among Patients With PsA
10/04/2023
Alexis Ogdie, MD
Dr Ogdie answers our questions about achieving minimal disease activity among patients with psoriatic arthritis treated with biologic and targeted synthetic DMARDs.
Dr Ogdie answers our questions about achieving minimal disease activity among patients with psoriatic arthritis treated with biologic and targeted synthetic DMARDs.
Dr Ogdie answers our questions...
10/04/2023
Rheumatology & Arthritis
Dr Ching-Lung Cheung
Q&A
Ching-Lung Cheung, PhD, on the Health Burden of Osteoporotic Fractures Among the Aging Population
09/29/2023
Ching-Lung Cheung, PhD
Dr Cheung agreed to answer a few question about his recent study highlighting an urgent need for better strategies in hip fracture prevention and care.
Dr Cheung agreed to answer a few question about his recent study highlighting an urgent need for better strategies in hip fracture prevention and care.
Dr Cheung agreed to answer a few...
09/29/2023
Rheumatology & Arthritis
Monica Schwartzman
Q&A
Monica Schwartzman, MD, on Medication Preferences Among Patients With PsA
08/21/2023
Monica Schwartzman, MD
Dr Schwartzman answered our questions about her recent study of what patients with psoriatic arthritis want most from their medical therapy.
Dr Schwartzman answered our questions about her recent study of what patients with psoriatic arthritis want most from their medical therapy.
Dr Schwartzman answered our...
08/21/2023
Rheumatology & Arthritis
Lars Klareskog, MD
Q&A
Lars Klareskog, MD, on the Study of Occupational Exposures and Risk of RA
08/08/2023
Lars Klareskog, MD
Dr Klareskog agreed to answer a few questions about this study on whether occupational inhalable agents present major risks in the development of rheumatoid arthritis, particularly among smokers and among those with a genetic predisposition...
Dr Klareskog agreed to answer a few questions about this study on whether occupational inhalable agents present major risks in the development of rheumatoid arthritis, particularly among smokers and among those with a genetic predisposition...
Dr Klareskog agreed to answer a...
08/08/2023
Rheumatology & Arthritis
Yassein Shamout, MD, FRCPC, DABD
Q&As
Optimizing Patient Care: Collaboration Between Dermatology and Rheumatology
06/20/2023
Jessica Garlewicz
A recent abstract published in the Journal of Cutaneous Medicine and Surgery reviewed and created a risk stratification strategy for early referral of patients with psoriatic arthritis.
A recent abstract published in the Journal of Cutaneous Medicine and Surgery reviewed and created a risk stratification strategy for early referral of patients with psoriatic arthritis.
A recent abstract published in...
06/20/2023
The Dermatologist
Laura Coates
Q&A
Laura Coates, MBChB, on GRAPPA Guidelines on PsA
06/02/2023
Laura Coates, MBChB
Dr Laura Coates of the University of Oxford (UK) details some key changes in the recommendations of the The Group for Research and Assessment of Psoriasis and Psoriatic Arthritis on treatment of PsA, comorbities and associated conditions.
Dr Laura Coates of the University of Oxford (UK) details some key changes in the recommendations of the The Group for Research and Assessment of Psoriasis and Psoriatic Arthritis on treatment of PsA, comorbities and associated conditions.
Dr Laura Coates of the...
06/02/2023
Rheumatology & Arthritis
Jennifer L Barton, MD, MCR
Q&As
Jennifer L Barton, MD, on Goal Elicitation for Patients with RA
01/06/2023
In this Q&A, Dr. Barton discusses the development of a goal elicitation tool for patients with rheumatoid arthritis.
In this Q&A, Dr. Barton discusses the development of a goal elicitation tool for patients with rheumatoid arthritis.
In this Q&A, Dr. Barton...
01/06/2023
Rheumatology & Arthritis
Saundra Jain
Q&A
Wellness in Rheumatic Diseases: A Conversation with Saundra Jain, MS, PsyD, and Andrew Laster, MD
09/30/2022
Saundra Jain, MA, PsyD, LPC
In this Q&A, Saundra Jain, MS, PsyD, and Andrew Laster, MD, discuss the concept of wellness in the context of rheumatic diseases and inflammatory arthritis.
In this Q&A, Saundra Jain, MS, PsyD, and Andrew Laster, MD, discuss the concept of wellness in the context of rheumatic diseases and inflammatory arthritis.
In this Q&A, Saundra Jain, MS,...
09/30/2022
Rheumatology & Arthritis
Dana Villmore
Q&A
Dana Villmore, PhD, Pa-C, on Treating Fibromyalgia in a Primary Care Setting
07/20/2022
In this Q&A, Dana Villmore, PhD, Pa-C, discusses the diagnosis and management of fibromyalgia for primary care providers.
In this Q&A, Dana Villmore, PhD, Pa-C, discusses the diagnosis and management of fibromyalgia for primary care providers.
In this Q&A, Dana Villmore, PhD,...
07/20/2022
Rheumatology & Arthritis
Betty Hsaio
Q&A
Betty Hsiao, MD, on Patient Conceptualization of RA Treatment
07/19/2022
Dr Betty Hsiao, from the Yale New Haven Medical Center and a medical advisor to CreakyJoints, presented an abstract at EULAR 2022 on understanding heterogeneity in patients' conceptualization of treatment for rheumatoid arthritis.
Dr Betty Hsiao, from the Yale New Haven Medical Center and a medical advisor to CreakyJoints, presented an abstract at EULAR 2022 on understanding heterogeneity in patients' conceptualization of treatment for rheumatoid arthritis.
Dr Betty Hsiao, from the Yale...
07/19/2022
Rheumatology & Arthritis

About Us

Rheumatology and Arthritis Learning Network® is an online resource for the latest developments in rheumatology practice, providing a customized experience for readers to stay informed about the topics that matter most to them.

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use